288 related articles for article (PubMed ID: 23152586)
1. Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.
Milber JM; Noorigian JV; Morley JF; Petrovitch H; White L; Ross GW; Duda JE
Neurology; 2012 Dec; 79(24):2307-14. PubMed ID: 23152586
[TBL] [Abstract][Full Text] [Related]
2. Incidental Lewy body disease and preclinical Parkinson disease.
DelleDonne A; Klos KJ; Fujishiro H; Ahmed Z; Parisi JE; Josephs KA; Frigerio R; Burnett M; Wszolek ZK; Uitti RJ; Ahlskog JE; Dickson DW
Arch Neurol; 2008 Aug; 65(8):1074-80. PubMed ID: 18695057
[TBL] [Abstract][Full Text] [Related]
3. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
4. Parkinson disease and incidental Lewy body disease: Just a question of time?
Iacono D; Geraci-Erck M; Rabin ML; Adler CH; Serrano G; Beach TG; Kurlan R
Neurology; 2015 Nov; 85(19):1670-9. PubMed ID: 26468408
[TBL] [Abstract][Full Text] [Related]
5. Neurodegeneration in Parkinson disease: moving Lewy bodies out of focus.
Schulz-Schaeffer WJ
Neurology; 2012 Dec; 79(24):2298-9. PubMed ID: 23152588
[No Abstract] [Full Text] [Related]
6. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.
Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314
[TBL] [Abstract][Full Text] [Related]
7. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
[TBL] [Abstract][Full Text] [Related]
8. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
9. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
[TBL] [Abstract][Full Text] [Related]
10. Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.
Parkkinen L; O'Sullivan SS; Collins C; Petrie A; Holton JL; Revesz T; Lees AJ
J Parkinsons Dis; 2011; 1(3):277-86. PubMed ID: 23939308
[TBL] [Abstract][Full Text] [Related]
11. Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.
Lang A; Dassler E; Milenkovic I; Lutz MI; Kovacs GG
Parkinsonism Relat Disord; 2021 Sep; 90():57-61. PubMed ID: 34385008
[TBL] [Abstract][Full Text] [Related]
12. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
[TBL] [Abstract][Full Text] [Related]
13. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
14. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.
Beach TG; Adler CH; Sue LI; Peirce JB; Bachalakuri J; Dalsing-Hernandez JE; Lue LF; Caviness JN; Connor DJ; Sabbagh MN; Walker DG
Acta Neuropathol; 2008 Apr; 115(4):445-51. PubMed ID: 17985144
[TBL] [Abstract][Full Text] [Related]
15. Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.
Lv Z; Jiang H; Xu H; Song N; Xie J
J Neural Transm (Vienna); 2011 Mar; 118(3):361-9. PubMed ID: 20556443
[TBL] [Abstract][Full Text] [Related]
16. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
Kingsbury AE; Bandopadhyay R; Silveira-Moriyama L; Ayling H; Kallis C; Sterlacci W; Maeir H; Poewe W; Lees AJ
Mov Disord; 2010 Nov; 25(15):2508-15. PubMed ID: 20818670
[TBL] [Abstract][Full Text] [Related]
17. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M
Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558
[TBL] [Abstract][Full Text] [Related]
18. Does levodopa accelerate the pathologic process in Parkinson disease brain?
Parkkinen L; O'Sullivan SS; Kuoppamäki M; Collins C; Kallis C; Holton JL; Williams DR; Revesz T; Lees AJ
Neurology; 2011 Oct; 77(15):1420-6. PubMed ID: 21917769
[TBL] [Abstract][Full Text] [Related]
19. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?
Frigerio R; Fujishiro H; Ahn TB; Josephs KA; Maraganore DM; DelleDonne A; Parisi JE; Klos KJ; Boeve BF; Dickson DW; Ahlskog JE
Neurobiol Aging; 2011 May; 32(5):857-63. PubMed ID: 19560232
[TBL] [Abstract][Full Text] [Related]
20. Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment.
Korecka JA; Eggers R; Swaab DF; Bossers K; Verhaagen J
Restor Neurol Neurosci; 2013; 31(2):155-67. PubMed ID: 23271419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
